Fig. 6From: Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratificationAssociation between annotated metabolites and disease progression and analysis of gene expression data. PSA progression-free survival calculated by the Kaplan Meier method for (a) suberic acid and (b) indoleacetic acid and lymph node progression-free survival for indoleacetic acid is represented in (c). Groups are defined by median-cut off of normalized abundances (low abundance, blue solid line) vs high abundance (red dotted line). P-value was estimated with log-rank test. IDO1 expression data of primary and androgen ablation resistant metastasis are shown from GSE6752 (d) and GSE6919 (e-f). ACADM expression data in the same set of samples are displayed in (g-h-i). Fold change (FC) is calculated versus the normal or primary tumor samples and p-value (P) for significance between two groups estimated by t-test. For statistical details see Methods sectionBack to article page